The Europe Cholesterol Testing Market is expected to reach USD 2,572.27 million by 2025, from USD 1,408.99 million in 2017 growing at a CAGR of 7.9% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
The major factors driving the market are technological advancements in cholesterol testing, growing number of cardiovascular diseases and obesity, higher growing number of geriatric population, rising awareness and acceptance of preventive healthcare, increasing cholesterol home/self-testing market. The cholesterol testing market in the EU region is leading in UK.
Get Free Report Sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=europe-cholesterol-testing-market
Europe Cholesterol Testing Market
By Product Type
• Test Kits,
• Testing Strips
By Test
• Lipid Panel Test/Complete Lipid Profile,
By Test Type
• Non-Invasive,
• Invasive
By Prescription Mode
• Over The Counter,
• Prescription Based
By End-Users
• Clinics,
• Hospitals,
• Ambulatory Centers,
• Homecare,
• Diagnostic Centers
By Country
• Germany,
• United Kingdom,
• France,
• Spain,
• Italy,
• Russia,
• Turkey,
• Belgium,
• Nether lands,
• Switzerland,
• Rest of Europe
Read Full TOC with Tables at @ https://databridgemarketresearch.com/toc/?dbmr=europe-cholesterol-testing-market
Market Segmentation: Europe Cholesterol Testing Market
• The Europe cholesterol testing market is segmented on the basis of product type, test, test type, prescription mode, and end-users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
• The Europe cholesterol testing market is segmented based on product type into testing strips and test kits. In 2018, test kits segment is expected to dominate the EU cholesterol testing market with 64.6% market share and is expected to reach USD 1,676.27 million by 2025, growing at the highest CAGR of 8.0% in the forecast period 2018 to 2025.
• The Europe cholesterol testing market is segmented on the basis of test into lipid panel test/complete lipid profile, apolipoprotein b test, apolipoprotein A-1 test, APOE genotyping test, apolipoprotein CII and others. In 2018, lipid panel test/complete lipid profile segment is expected to dominate the EU cholesterol testing market with 44.2% market share and is expected to reach USD 1,172.34 million by 2025, growing at the highest CAGR of 8.4% in the forecast period 2018 to 2025.
• The Europe cholesterol testing market is segmented on the basis of test type into non-invasive and invasive. In 2018, invasive market segment is expected to dominate the EU cholesterol testing market with 73.5% market share and is expected to reach USD 1,868.58 million by 2025, growing at a CAGR of 7.7% in the forecast period 2018 to 2025. However, non-invasive is expected to grow at the highest CAGR of 8.4% in the forecast period, and is expected to reach USD 703.69 million in 2025 from USD 371.89 million in 2017.
• The Europe cholesterol testing market is segmented on the basis of prescription mode into over the counter and prescription based. In 2018, prescription based market segment is expected to dominate the EU cholesterol testing market with 80.2% market share and is expected to reach USD 2,093.98 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.
• The Europe cholesterol testing market is segmented on the basis of prescription mode into end users, clinics, hospitals, ambulatory centers, homecare and diagnostic centers. In 2018, hospitals are expected to dominate the EU cholesterol testing market with 48.4% market share and are expected to reach USD 1,281.24 million by 2025, growing at the highest CAGR of 8.4% in the forecast period 2018 to 2025.
Inquiry before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-cholesterol-testing-market
Key Drivers: Europe Cholesterol Testing Market
The major factors driving the market are technological advancements in cholesterol testing, growing number of cardiovascular diseases and obesity, higher growing number of geriatric population, rising awareness and acceptance of preventive healthcare, increasing cholesterol home/self-testing market.
Key Points: Europe Cholesterol Testing Market
• In 2017, the Europe cholesterol testing market is dominated by F. Hoffmann-La Roche Ltd, followed by Siemens AG and Abbott 19.5%
• Test Kits segment is dominating the Europe cholesterol testing However, magnetic tracers are expected to dominate the EU cholesterol testing market in the forecast period.
• The cholesterol testing market in the Europe region is leading in U.K.
For more information about this report visit @ https://databridgemarketresearch.com/reports/europe-cholesterol-testing-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]